Evidence map›Paper›PMID 24311556›Full record

ArticleMicrobiologyOpen2013

Spoligotyping and drug resistance patterns of Mycobacterium tuberculosis isolates from five provinces of Iran.

Mehri Haeili, Davood Darban-Sarokhalil, Abbas Ali Imani Fooladi, Sedigheh Javadpour, Abdorrazagh Hashemi, Farideh Siavoshi, Mohammad Mehdi Feizabadi

Abstract read
In one paragraph

Article in MicrobiologyOpen, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Molecular Characterization ofHealth science reports · 2026
    Article
  4. Antimicrobial resistance profile and prevalence ofJournal of clinical tuberculosis and other mycobacterial diseases · 2024
    Article
  5. Article
  6. Article
  7. Article
  8. Genotyping and drug susceptibility testing ofNew microbes and new infections · 2020
    Article
  9. Article
  10. Spoligotype and Drug Susceptibility Profiles ofInfection and drug resistance · 2020
    Article
  11. Article
  12. Article
  13. Review
  14. Resistance ofHeliyon · 2019
    Article
  15. New microbes and new infections · 2018
    Article
  16. High genetic diversity amongJournal of clinical tuberculosis and other mycobacterial diseases · 2018
    Article
  17. Genetic Diversity of Drug-resistantAdvanced biomedical research · 2018
    Article
  18. The high prevalence ofIranian journal of microbiology · 2017
    Article
  19. Emerging and re-emerging infectious diseases in Iran.Iranian journal of microbiology · 2017
    Review
  20. Molecular typing methods used in studies ofIranian journal of microbiology · 2016
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Mehri HaeiliDepartment of Microbiology, School of Biology, College of Science, University of Tehran, Tehran, Iran; Department of Microbiology, School of Medicine, Tehran University of Medical Sciences, Tehran, Iran.
Davood Darban-Sarokhalil
Abbas Ali Imani Fooladi
Sedigheh Javadpour
Abdorrazagh Hashemi
Farideh Siavoshi
Mohammad Mehdi Feizabadi

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Tuberculosis (TB) persists as a public health problem in Iran. Characterization of Mycobacterium tuberculosis isolates circulating in this area will contribute to understand and control the spread of the strains. The aims of this study were to understand the genetic diversity and drug susceptibility of M. tuberculosis isolates circulating in Iran and to analyze the relationship between genotype and drug resistance. A total of 291 M. tuberculosis isolates collected from TB patients were genotyped by spoligotyping. Drug susceptibility testing was performed using proportion method. Spoligotyping resulted in 75 distinct patterns. 86.2% of isolates were grouped in 35 clusters while the remaining isolates were unique. Ural was found to be the most predominant lineage (34.3%) followed by Central Asian strain (CAS) (24%), T (18.2%), Manu2 (7.5%) and Latin American-Mediterranean (LAM) (6.1%). The five largest clusters were Ural/Spoligotype International Type (SIT)127 (15.8%), CAS1/SIT26 (9.2%), T1/SIT53 (6.1%), T1/SIT284 (5.4%), and CAS1/SIT25 (4.4%). About 5% of isolates had multidrug resistance (MDR) and 10% had other resistance. MDR was significantly associated with Beijing strains, but not with Ural family. This study highlights dominance of Ural, CAS, and T families in Iran. Biogeographic specificity of CAS and T families to border provinces of Iran including Sistan-Baluchestan and Kermanshah, respectively, suggested that this family strains might be transmitted from these regions to other provinces of the country.

Indexed as

Drug Resistance, BacterialMolecular TypingAntitubercular AgentsCluster AnalysisGenotypeHumansIranMicrobial Sensitivity TestsMolecular EpidemiologyMycobacterium tuberculosisPhylogeographyTuberculosisAntitubercular AgentsIranMDR-TBMycobacterium tuberculosisspoligotyping.

Identifiers

PMID24311556
PMCPMC3892344

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.